ArticleFrontiers in reproductive health2026
Regulating algorithmic tools in reproductive health: ethical and legal challenges.
Article in Frontiers in reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence and algorithmic tools are increasingly integrated into reproductive healthcare, including fertility tracking applications, diagnostic systems, and clinical decision support tools. While these technologies may support improved access, personalisation, and decision making, their expansion is also associated with significant ethical and governance challenges in a domain shaped by legal risk, social norms, and deeply personal health decisions. These challenges include limited transparency, which may constrain informed consent and autonomy; risks of bias arising from unrepresentative data; heightened privacy concerns linked to sensitive reproductive information; and unclear accountability across developers, clinicians, and institutions. Importantly, these risks are not uniform, but are shaped by legal, social, and health system conditions, and may be particularly pronounced in low resource and legally restrictive settings. Despite growing attention to AI ethics, existing frameworks and guidance often remain high level and do not fully address how these challenges should be governed in context-sensitive reproductive health settings. This paper advances a governance-oriented perspective that integrates Healthcare 5.0 and reproductive justice frameworks to examine how these challenges emerge within adaptive socio-technical systems. It argues that existing governance approaches remain insufficiently responsive to structural and intersectional vulnerabilities and proposes a context aware approach that embeds human oversight, explainability, privacy protection, and accountability as core system level requirements. By positioning reproductive health as a critical test case for AI governance, this perspective highlights the need for enforceable, context-sensitive approaches that prioritise equity, autonomy, and the lived realities of affected populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.